Menstrual blood derived mesenchymal stem cells (Ipm Biopharm)

宫血间充质干细胞 （浙江生创）

Report date: 2026/01/15 16:37:11

Base Information

Drug NameMenstrual blood derived mesenchymal stem cells (Ipm Biopharm)
Drug Alias NameSC01009SC-01009
ClassificationCell and gene therapy > Cell therapy > Source of cells > Uterine blood-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDecompensated Liver CirrhosisRespiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesIpm Biopharm Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesIpm Biopharm Co LtdZhejiang University
Inactive CompaniesN/A
Active IndicationsDecompensated Liver CirrhosisRespiratory Distress Syndrome, AdultIdiopathic Pulmonary Fibrosis +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A